Statines en prévention primaire: comment décider avec le patient [Statins in primary prevention: how to share the decision?].


Autoria(s): Nanchen D.; Vonnez J.L.; Selby K.; Auer R.; Cornuz J.
Data(s)

2015

Resumo

Long-term treatment of hypercholesterolemia with statins diminishes the risk of cardiovascular events. Statins are recommended in secondary prevention of cardiovascular disease. In the absence of preexisting cardiovascular disease, the decision to start a statin or not is most often made by the general practitioner and his patient. An interactive decision aid, developed by the Mayo Clinic, has just been translated in French and adapted to the Swiss epidemiology of cardiovascular risk factors, with the aim of promoting shared decision-making. This paper reviews the conditions and potential benefits of shared decision-making about statin therapy in primary prevention.

Identificador

http://serval.unil.ch/?id=serval:BIB_A5FB41798903

isbn:1660-9379 (Print)

pmid:26742352

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 11, no. 496, pp. 2222-2226

Tipo

info:eu-repo/semantics/article

article